{"id":2341,"date":"2023-10-05T13:41:21","date_gmt":"2023-10-05T17:41:21","guid":{"rendered":"http:\/\/haidut.me\/?p=2341"},"modified":"2023-10-12T11:05:19","modified_gmt":"2023-10-12T15:05:19","slug":"serotonin-5-ht-drives-diabetes-and-liver-disease-blocking-it-is-therapeutic","status":"publish","type":"post","link":"https:\/\/haidut.me\/?p=2341","title":{"rendered":"Serotonin (5-HT) drives diabetes and liver disease, blocking it is therapeutic"},"content":{"rendered":"<p>After more than a decade of doing research in bioenergetics, I have come to the conclusion that there is hardly a disease (both acute and chronic) where 5-HT is not involved as a causal factor. Out of all those conditions, the ones with the biggest public health impacts are probably obesity, diabetes, and liver disease and those are usually present together (i.e. co-morbidities) in a patient. Despite official claims that the cause of these widespread conditions is eating too much (and especially sugar) and moving too little, the fact that even wild animals living close to humans are getting fat and diabetic virtually guarantees that the cause is environmental. Putting the eternal villain PUFA aside, another ubiquitous environmental factor is the usage of serotonergic drugs, as well as the presence of chronic stress &#8211; both resulting in increased serotonergic tone by themselves and greatly synergistic in combination. The study below demonstrates that elevated 5-HT leads to hyperglycemia, hyperlipidemia, insulin resistance, and hepatic steatosis\/inflammation\/fibrosis through the activation of the 5-HT2 receptor. Conversely, lowering 5-HT synthesis by administration of an inhibitor of tryptophan hydroxylase (TPH, rate-limiting step in serotonin synthesis) and\/or blocking the 5-HT2 receptor (with a serotonin antagonist) lead to amelioration (and even reversal) of most of these pathologies. Btw, it is probably just a &#8220;coincidence&#8221; that despite medicine continuing to gaslight the public about 5-HT being the &#8220;happiness&#8221; hormone, behind the scenes many companies are running clinical trials with TPH inhibitors or serotonin receptor antagonists as curative treatments for a host of incurable conditions including pulmonary\/cardiac fibrosis, as well as the more &#8220;benign&#8221; but much more widespread conditions collectively known as the metabolic syndrome.<\/p>\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27133527\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/27133527\/<\/a><\/p>\n<p><a href=\"https:\/\/karger.com\/cpb\/article\/48\/6\/2409\/75186\/Crucial-Roles-of-5-HT-and-5-HT2-Receptor-in\">https:\/\/karger.com\/cpb\/article\/48\/6\/2409\/75186\/Crucial-Roles-of-5-HT-and-5-HT2-Receptor-in<\/a><\/p>\n<p>&#8220;&#8230;These effects of the 5-HT system were also detected in palmitic acid- or high glucose-treated PMHs and regulated multiple inflammatory signaling pathways. In diabetic mice, <span style=\"text-decoration: underline;\"><strong>co-treatment with <span style=\"color: #ff0000; text-decoration: underline;\">antagonists of both 5-HT synthesis and 5-HT<sub>2<\/sub>R significantly abolished hepatic steatosis, inflammation, and fibrosis as well as hyperglycemia and dyslipidemia<\/span><\/strong><\/span>.\u00a0<strong><em>Conclusion:<\/em><\/strong>\u00a0Activation of the hepatocellular <span style=\"text-decoration: underline; color: #000000;\"><strong>5-HT system plays a crucial role in inducing diabetes-related hepatic dysfunction<\/strong><\/span> and is a potential therapeutic target.&#8221;<\/p>\n<p>&#8220;&#8230;Numerous patients with T2DM develop NAFLD with inflammatory complications, namely, NASH. However, the mechanisms underlying these processes are not understood entirely. We revealed that the <span style=\"text-decoration: underline; color: #000000;\"><strong>5-HT system, including 5-HT synthesis and 5-HT<sub>2<\/sub>R, is activated in the hepatocytes of a T2DM mouse model, which crucially affected the occurrence of hepatic steatosis and inflammation with fibrosis<\/strong><\/span>. 5-HT<sub>2<\/sub>R activation in hepatocytes regulates PKC\u03b5 activation with the subsequent phosphorylation of Akt, mTOR, and ERK1\/2, ultimately resulting in ELS, including\u00a0<em>de novo<\/em>\u00a0lipogenesis, and TG and VLDL synthesis with LDA, whereas <span style=\"text-decoration: underline;\"><strong>the activation of both 5-HT synthesis and 5-HT<sub>2<\/sub>R modulates oxidative stress with the activation of NF-\u03baB and inflammatory signaling molecules, including p38, JNK, and STAT3, resulting in PICG<\/strong><\/span>.&#8221;<\/p>\n<p>&#8220;&#8230;We found that the<span style=\"color: #000000;\"> levels of dopamine<\/span>, another molecule synthesized by AADC, <span style=\"color: #000000;\">were very low<\/span> and unchanged <span style=\"color: #000000;\">in the liver and serum of Ctrl and T2DM mice<\/span> with or without CDP treatment (data not shown), whereas <span style=\"text-decoration: underline;\"><strong>5-HT levels were significantly elevated in the liver and serum of T2DM mice<\/strong><\/span>, and were obviously reduced by CDP treatment; hepatic 5-HT levels were also inhibited by Sar (Fig.\u00a0<a class=\"link link-reveal link-table xref-fig\" data-open=\"f08\">8<\/a>a). The expression of hepatic Tph1, AADC, 5-HT<sub>2A<\/sub>R, and 5-HT<sub>2B<\/sub>R was up-regulated in T2DM mice compared to Ctrl mice (Fig.\u00a0<a class=\"link link-reveal link-table xref-fig\" data-open=\"f08\">8<\/a>a). T2DM mice exhibited PKC\u03b5 activation with increased phosphorylation of Akt, mTOR, and ERK1\/2, upregulated ACC, GPAT1, and MTTP expression (Fig.\u00a0<a class=\"link link-reveal link-table xref-fig\" data-open=\"f08\">8<\/a>b), and increased TG and VLDL levels (Fig.\u00a0<a class=\"link link-reveal link-table xref-fig\" data-open=\"f08\">8<\/a>c) in the liver; they also showed hepatic oxidative stress and inflammation with up-regulated MAO-A expression, increased H<sub>2<\/sub>O<sub>2<\/sub>\u00a0and MDA levels, NF-\u03baB activation, increased phosphorylation of p38, JNK, and STAT3, and increased TNF-\u03b1 and IL-1\u03b2 levels (Fig.\u00a0<a class=\"link link-reveal link-table xref-fig\" data-open=\"f08\">8<\/a>b and c). <span style=\"text-decoration: underline;\"><strong>These alterations were remarkably inhibited by Sar and CDP in a synergistic manner<\/strong><\/span>.&#8221;<\/p>\n<p>&#8220;&#8230;By hematoxylin and eosin staining (Fig.\u00a0<a class=\"link link-reveal link-table xref-fig\" data-open=\"f08\">8<\/a>d), we found <span style=\"text-decoration: underline;\"><strong>hepatic steatosis and lobular inflammation with inflammatory cell infiltration and hepatocyte ballooning in the lobes<\/strong><\/span>. By Masson\u2019s trichrome staining (Fig.\u00a0<a class=\"link link-reveal link-table xref-fig\" data-open=\"f08\">8<\/a>e), we found <span style=\"text-decoration: underline;\"><strong>hepatic fibrosis in the periportal and parenchymal regions of T2DM mice<\/strong><\/span>. <span style=\"text-decoration: underline;\"><strong>These phenotypes were significantly ameliorated by Sar and CDP, <span style=\"color: #000000; text-decoration: underline;\">particularly by the combination of both<\/span><\/strong><\/span>. Additionally, increased hepatic levels of hydroxyproline (Fig.\u00a0<a class=\"link link-reveal link-table xref-fig\" data-open=\"f08\">8<\/a>c), a marked amino acid in the collagen of fibrous tissue [<a class=\"link link-ref xref-bibr\" data-modal-source-id=\"ref33\">33<\/a>], and liver injury with increased activity of serum ALT and AST (Fig.\u00a0<a class=\"link link-reveal link-table xref-fig\" data-open=\"f09\">9<\/a>c) were also <span style=\"text-decoration: underline;\"><strong>reversed significantly in T2DM mice by Sar and CDP <span style=\"color: #ff0000; text-decoration: underline;\">in a synergistic manner<\/span><\/strong><\/span>.&#8221;<\/p>\n<p>&#8220;&#8230;<span style=\"text-decoration: underline;\"><strong>Treatment with Sar and CDP, alone or in combination, reversed the bodyweight loss and reduced the increases in food intake and hepatic index in T2DM mice<\/strong><\/span> (Fig.\u00a0<a class=\"link link-reveal link-table xref-fig\" data-open=\"f09\">9<\/a>a). Whereas there was no significant difference between the three treatments for the amelioration of bodyweight loss, food intake, and hepatic index, suggesting that these effects are not crucial for treating NASH. <span style=\"text-decoration: underline;\"><strong>Sar and CDP treatment (alone or in combination) of T2DM mice also ameliorated dyslipidemia and IR in a synergistic manner<\/strong><\/span>, including a reduction of the increased serum levels of TG, FFAs, LDL-c, and VLDL-c, decreased serum levels of HDL-c (Fig.\u00a0<a class=\"link link-reveal link-table xref-fig\" data-open=\"f09\">9<\/a>b), <span style=\"text-decoration: underline;\"><strong>and increased levels of fasting blood glucose and serum insulin with an increased HOMA-IR index<\/strong><\/span> (Fig.\u00a0<a class=\"link link-reveal link-table xref-fig\" data-open=\"f09\">9<\/a>c). Taken together, our findings show that 5-HT system activation in the liver is a crucial event leading to T2DM-related NASH.&#8221;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>After more than a decade of doing research in bioenergetics, I have come to the conclusion that&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[192,285,64,12,59,60,319,47],"class_list":["post-2341","post","type-post","status-publish","format-standard","hentry","category-science","tag-5-ht","tag-diabetes","tag-fibrosis","tag-inflammation","tag-nafld","tag-nash","tag-obesity","tag-serotonin","wpcat-2-id"],"_links":{"self":[{"href":"https:\/\/haidut.me\/index.php?rest_route=\/wp\/v2\/posts\/2341","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haidut.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haidut.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haidut.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haidut.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2341"}],"version-history":[{"count":2,"href":"https:\/\/haidut.me\/index.php?rest_route=\/wp\/v2\/posts\/2341\/revisions"}],"predecessor-version":[{"id":2354,"href":"https:\/\/haidut.me\/index.php?rest_route=\/wp\/v2\/posts\/2341\/revisions\/2354"}],"wp:attachment":[{"href":"https:\/\/haidut.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2341"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haidut.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2341"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haidut.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}